Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending July 5, 2015
Causes of Mortality Among Men With RA, What are the key associations?
Adherence to SLE Therapies, Correlating nonadherence with ER visits and hospitalizations
Epidemiology and Treatment in RA, Tracking prescription of antirheumatics
Ustekinumab in PsA, Do efficacy and radiographic benefits last?
Must reads for theWeek ending June 14, 2015
Insomnia and Pain in Patients With Knee OA, Can behavior modification provide relief?
Adalimumab in Nonpsoriatic Peripheral Spondyloarthritis, When NSAIDS are inadequate
Pain and Spondyloarthritis in Psoriasis, Do psoriasis patients have more pain?
Serious Infections Among SLE and LN Patients, Sex, race, and therapies influence infection rates
Infection Risk for RA Patients Treated With a Biologic, Comparing denosumab with zoledronate as adjuvants
Must reads for theWeek ending May 24, 2015
Assessing RA and Coronary Atherosclerosis, Can the GlycA biomarker help the assessment?
Breast Cancer Risk for Female Lupus Patients, Is their risk really lower?
Knee Replacement in RA Patients, Does RA increase risk of adverse events?